Autolus Therapeutics

-$0.22 (-3.58%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUTL and other ETFs, options, and stocks.

About AUTL

Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells.

CEO
Christian Martin Itin
Employees
384
Headquarters
London, Greater London
Founded
2018

AUTL Key Statistics

Market Cap
430.64M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
259.35K
High Today
$6.22
Low Today
$5.86
Open Price
$6.13
Volume
182.53K
52 Week High
$12.33
52 Week Low
$4.60

AUTL Earnings

-$0.83
-$0.55
-$0.28
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure